ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 128 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,000 | -62.8% | 12,573 | -48.7% | 0.00% | – |
| Q4 2021 | $43,000 | -71.3% | 24,489 | -64.5% | 0.00% | -100.0% |
| Q3 2021 | $150,000 | -26.1% | 68,934 | +234.8% | 0.00% | 0.0% |
| Q1 2021 | $203,000 | +23.8% | 20,591 | +36.3% | 0.00% | 0.0% |
| Q4 2020 | $164,000 | -83.8% | 15,102 | -84.6% | 0.00% | -83.3% |
| Q3 2020 | $1,012,000 | +316.5% | 98,254 | +743.6% | 0.01% | +200.0% |
| Q2 2020 | $243,000 | -49.7% | 11,647 | -76.4% | 0.00% | -60.0% |
| Q1 2020 | $483,000 | +135.6% | 49,386 | +31.5% | 0.01% | +150.0% |
| Q3 2019 | $205,000 | +241.7% | 37,544 | +230.4% | 0.00% | +100.0% |
| Q1 2019 | $60,000 | +5.3% | 11,364 | +5.5% | 0.00% | 0.0% |
| Q2 2018 | $57,000 | – | 10,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |